Telo Genomics Corp Stock Probability of Future Stock Price Finishing Over 23.02
Telo Genomics' future price is the expected price of Telo Genomics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Telo Genomics Corp performance during a given time horizon utilizing its historical volatility. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Please specify Telo Genomics' target price for which you would like Telo Genomics odds to be computed.
Telo |
Telo Genomics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Telo Genomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Telo Genomics Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Telo Genomics Corp is not yet fully synchronised with the market data | |
| Telo Genomics Corp has some characteristics of a very speculative penny stock | |
| Telo Genomics Corp has high likelihood to experience some financial distress in the next 2 years | |
| Telo Genomics Corp has accumulated 32.5 K in total debt. Telo Genomics Corp has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Telo Genomics until it has trouble settling it off, either with new capital or with free cash flow. So, Telo Genomics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Telo Genomics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Telo to invest in growth at high rates of return. When we think about Telo Genomics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (2.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Telo Genomics Corp has accumulated about 24.25 K in cash with (2.63 M) of positive cash flow from operations. |
Telo Genomics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Telo Stock often depends not only on the future outlook of the current and potential Telo Genomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Telo Genomics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 60.2 M | |
| Cash And Short Term Investments | 2.7 M |
Telo Genomics Technical Analysis
Telo Genomics' future price can be derived by breaking down and analyzing its technical indicators over time. Telo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Telo Genomics Corp. In general, you should focus on analyzing Telo Stock price patterns and their correlations with different microeconomic environments and drivers.
Telo Genomics Predictive Forecast Models
Telo Genomics' time-series forecasting models is one of many Telo Genomics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Telo Genomics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Telo Genomics Corp
Checking the ongoing alerts about Telo Genomics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Telo Genomics Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Telo Genomics Corp is not yet fully synchronised with the market data | |
| Telo Genomics Corp has some characteristics of a very speculative penny stock | |
| Telo Genomics Corp has high likelihood to experience some financial distress in the next 2 years | |
| Telo Genomics Corp has accumulated 32.5 K in total debt. Telo Genomics Corp has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Telo Genomics until it has trouble settling it off, either with new capital or with free cash flow. So, Telo Genomics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Telo Genomics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Telo to invest in growth at high rates of return. When we think about Telo Genomics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (2.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Telo Genomics Corp has accumulated about 24.25 K in cash with (2.63 M) of positive cash flow from operations. |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Tools for Telo Stock
When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |